CanniMed Therapeutics CEO Brent Zettl has resigned, effective immediately, as Aurora Cannabis nears completion of its acquisition of the medical marijuana company.
Zettl, who helped co-found the Saskatoon-based licensed producer in 1988, is pursuing other opportunities, the companies said in a statement.
Aurora’s senior vice president of business integration Andre Jerome has been appointed as interim chief executive.
In January, Aurora struck a stock-and-cash deal valued at $1.1 billion to buy CanniMed.
The agreement ended a sometimes-terse takeover battle between the two marijuana companies.
The Canadian Press[share-btn]